TFS
ABMD

TrustCore Financial Services’s Abiomed Inc ABMD Stock Holding History

TrustCore Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-129
Closed -$32K – 1206
2022
Q2 		$32K Hold
129
– – ﹤0.01% 545
2022
Q1 		$43K Hold
129
– – ﹤0.01% 511
2021
Q4 		$46K Hold
129
– – 0.01% 459
2021
Q3 		$42K Buy
+129
New +$43.7K ﹤0.01% 518

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

TrustCore Financial Services's ABMD Position: Q3 2022 in Review

TrustCore Financial Services sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 129 shares — an estimated $32K sold.

TrustCore Financial Services first reported a position in ABMD in Q3 2021 and held it in 4 quarters. The position peaked at $46K in Q4 2021. 516 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • TrustCore Financial Services reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 129 Abiomed Inc shares in Q3 2022, an estimated $32K.
  • TrustCore Financial Services first reported a position in Abiomed Inc in Q3 2021 and held it in 4 quarters.
  • TrustCore Financial Services's Abiomed Inc position peaked at $46K in Q4 2021.
  • 516 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.